FDA extends deadline for public comments on CBD rules

U.S. health regulators are giving hemp entrepreneurs and the public more time to weigh in on looming CBD rules.

The U.S. Food and Drug Administration said in an announcement posted Thursday that comments will be accepted until July 16, two weeks longer than before.

The FDA forbids the use of CBD in ingestible products such as food and dietary supplements.

But the FDA has only sporadically enforced its ban, and some states have given CBD manufacturers express permission to make and sell CBD foods, drinks and dietary supplements.

FDA officials leading the CBD review said earlier this week the agency is “committed to evaluating the regulatory frameworks for nondrug uses, including products marketed as foods and dietary supplements.”